Please assess the completion status of the following clinical trial:

Trial Title: Nutraceutical Citrulline in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Singleton pregnancy~* Type 2 diabetes with hemoglobin A1c \<8~* Gestational age at randomization between 14 and 16 weeks based on clinical information~* Maternal age between 14 and 40 years~Exclusion Criteria:~* Chronic hypertension~* Major fetal anomaly~* Fetal demise~* Planned termination of the pregnancy~* Collagen vascular disease (autoimmune disease) on medication~* Renal disease~* Epilepsy or other seizure disorder~* Active or chronic liver disease~* Heart disease, known illicit drug or alcohol abuse during current pregnancy~* Already taking L-citrulline as a supplement (1gram/day or more)

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Citrulline (Type: EXPERIMENTAL): Oral L-citrulline, 3 grams once per day for 3 weeks.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, 3 grams once per day for 3 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).